Prediction of histopathologic grades of myxofibrosarcoma with radiomics based on magnetic resonance imaging

被引:3
|
作者
Yao, Yubin [1 ]
Zhao, Yan [2 ]
Lu, Liejing [3 ]
Zhao, Yongqiang [4 ]
Lin, Xiaokun [5 ]
Xia, Jianfeng [6 ]
Zheng, Xufeng [1 ]
Shen, Yi [1 ]
Cai, Zonghuan [1 ]
Li, Yangkang [7 ]
Yang, Zehong [3 ]
Lin, Daiying [1 ]
机构
[1] Shantou Cent Hosp, Dept Radiol, 114 Waima Rd, Shantou 515031, Peoples R China
[2] Shantou Cent Hosp, Clin Res Ctr, Cent Lab, 114 Waima Rd, Shantou 515031, Peoples R China
[3] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Radiol, 107 Yanjiang Rd West, Guangzhou 510120, Peoples R China
[4] Shantou Cent Hosp, Dept Pathol, 114 Waima Rd, Shantou 515031, Peoples R China
[5] First Peoples Hosp Jiexi, Dept Radiol, 7 Dangxiao Rd, Jieyang 515400, Peoples R China
[6] First Peoples Hosp Qinzhou, Dept Radiol, 47 Qianjin Rd, Qinzhou 535000, Peoples R China
[7] Shantou Univ, Canc Hosp, Med Coll, Dept Radiol, 7 Raoping Rd, Shantou 515041, Peoples R China
关键词
Myxofibrosarcoma; Histopathological grading; Radiomics; Nomogram; CANCER-CENTERS-SARCOMA; SOFT-TISSUE SARCOMAS; NEOADJUVANT CHEMOTHERAPY; FRENCH-FEDERATION; ADULT PATIENTS; DIAGNOSIS; TUMORS;
D O I
10.1007/s00432-023-04939-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeTo develop a radiomics-based model from preoperative magnetic resonance imaging (MRI) for predicting the histopathological grades of myxofibrosarcoma.MethodsThis retrospective study included 54 patients. The tumors were classified into high-grade and low-grade myxofibrosarcoma. The tumor size, signal intensity heterogeneity, margin, and surrounding tissue were evaluated on MRI. Using the least absolute shrinkage and selection operator (LASSO) algorithms, 1037 radiomics features were obtained from fat-suppressed T2-weighted images (T2WI), and a radiomics signature was established. Using multivariable logistic regression analysis, three models were built to predict the histopathologic grade of myxofibrosarcoma. A radiomics nomogram represents the integrative model. The three models' performance was evaluated using the receiver operating characteristics (ROC) and calibration curves.ResultsThe high-grade myxofibrosarcoma had greater depth (P = 0.027), more frequent heterogeneous signal intensity at T2WI (P = 0.015), and tail sign (P = 0.014) than the low-grade tumor. The area under curve (AUC) of these conventional MRI features models was 0.648, 0.656, and 0.668, respectively. Seven radiomic features were selected by LASSO to construct the radiomics signature model, with an AUC of 0.791. The AUC of the integrative model based on radiomics signature and conventional MRI features was 0.875. The integrative model's calibration curve and insignificant Hosmer-Lemeshow test statistic (P = 0.606) revealed good calibration.ConclusionAn integrative model using radiomics signature and three conventional MRI features can preoperatively predict low- or high-grade myxofibrosarcoma.
引用
收藏
页码:10169 / 10179
页数:11
相关论文
共 50 条
  • [1] Prediction of histopathologic grades of myxofibrosarcoma with radiomics based on magnetic resonance imaging
    Yubin Yao
    Yan Zhao
    Liejing Lu
    Yongqiang Zhao
    Xiaokun Lin
    Jianfeng Xia
    Xufeng Zheng
    Yi Shen
    Zonghuan Cai
    Yangkang Li
    Zehong Yang
    Daiying Lin
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 10169 - 10179
  • [2] Prediction of histopathologic grades of bladder cancer with radiomics based on MRI: Comparison with traditional MRI
    Li, Longchao
    Zhang, Jing
    Zhe, Xia
    Tang, Min
    Zhang, Li
    Lei, Xiaoyan
    Zhang, Xiaoling
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (06) : 176e9 - 176e20
  • [3] Correlation Between Magnetic Resonance Imaging and Histopathologic Grades in Rasmussen Syndrome
    Kim, Sun Jun
    Park, Yong D.
    Hessler, Richard
    Lee, Mark R.
    Smith, Joseph R.
    PEDIATRIC NEUROLOGY, 2010, 42 (03) : 172 - 176
  • [4] Clinical and Magnetic Resonance Imaging Radiomics-Based Survival Prediction in Glioblastoma Using Multiparametric Magnetic Resonance Imaging
    Bathla, Girish
    Soni, Neetu
    Ward, Caitlin
    Maheshwarappa, Ravishankar Pillenahalli
    Agarwal, Amit
    Priya, Sarv
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2023, 47 (06) : 919 - 923
  • [5] Prediction of meningioma grade by constructing a clinical radiomics model nomogram based on magnetic resonance imaging
    Han, Tao
    Liu, Xianwang
    Long, Changyou
    Xu, Zhendong
    Geng, Yayuan
    Zhang, Bin
    Deng, Liangna
    Jing, Mengyuan
    Zhou, Junlin
    MAGNETIC RESONANCE IMAGING, 2023, 104 : 16 - 22
  • [6] Multiparametric Magnetic Resonance Imaging-Based Peritumoral Radiomics for Preoperative Prediction of the Presence of Extracapsular Extension With Prostate Cancer
    Bai, Honglin
    Xia, Wei
    Ji, Xuefu
    He, Dong
    Zhao, Xingyu
    Bao, Jie
    Zhou, Jian
    Wei, Xuedong
    Huang, Yuhua
    Li, Qiong
    Gao, Xin
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2021, 54 (04) : 1222 - 1230
  • [7] Glioma grading prediction using multiparametric magnetic resonance imaging-based radiomics combined with proton magnetic resonance spectroscopy and diffusion tensor imaging
    Lin, Kun
    Cidan, Wangjiu
    Qi, Ying
    Wang, Xiaoming
    MEDICAL PHYSICS, 2022, 49 (07) : 4419 - 4429
  • [8] Feasibility of magnetic resonance imaging-based radiomics features for preoperative prediction of extrahepatic cholangiocarcinoma stage
    Huang, Xinqiao
    Shu, Jian
    Yan, Yulan
    Chen, Xin
    Yang, Chunmei
    Zhou, Tiejun
    Li, Man
    EUROPEAN JOURNAL OF CANCER, 2021, 155 : 227 - 235
  • [9] Magnetic Resonance Imaging Radiomics-Based Model for Prediction of Lymph Node Metastasis in Cervical Cancer
    Shi, Zhenjie
    Lu, Longlong
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2025, 18 : 1371 - 1381
  • [10] Radiomics Based on Multiparametric Magnetic Resonance Imaging to Predict Extraprostatic Extension of Prostate Cancer
    Xu, Lili
    Zhang, Gumuyang
    Zhao, Lun
    Mao, Li
    Li, Xiuli
    Yan, Weigang
    Xiao, Yu
    Lei, Jing
    Sun, Hao
    Jin, Zhengyu
    FRONTIERS IN ONCOLOGY, 2020, 10